Congenital cataracts-facial dysmorphism-neuropathy
- PMID: 16939648
- PMCID: PMC1563997
- DOI: 10.1186/1750-1172-1-32
Congenital cataracts-facial dysmorphism-neuropathy
Abstract
Congenital Cataracts Facial Dysmorphism Neuropathy (CCFDN) syndrome is a complex developmental disorder of autosomal recessive inheritance. To date, CCFDN has been found to occur exclusively in patients of Roma (Gypsy) ethnicity; over 100 patients have been diagnosed. Developmental abnormalities include congenital cataracts and microcorneae, primary hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, mild facial dysmorphism and hypogonadism. Para-infectious rhabdomyolysis is a serious complication reported in an increasing number of patients. During general anaesthesia, patients with CCFDN require careful monitoring as they have an elevated risk of complications. CCFDN is a genetically homogeneous condition in which all patients are homozygous for the same ancestral mutation in the CTDP1 gene. Diagnosis is clinical and is supported by electrophysiological and brain imaging studies. The major differential diagnosis is Marinesco-Sjögren syndrome. The definitive diagnosis is molecular, based on homozygosity for the CTDP1 mutation. CTDP1 maps to 18qter and encodes a protein phosphatase whose only known substrate is the phosphorylated serine residues of the carboxy-terminal domain of the largest subunit of RNA polymerase II, indicating that CCFDN affects basic cellular processes of gene expression and developmental regulation. Families benefit from genetic counselling and predictive testing. Management includes surgical treatment of the cataracts, and rehabilitation and corrective orthopaedic surgery for the peripheral neuropathy. Thus, the most disabling manifestations, though not curable, are manageable, and allow an acceptable quality of life and everyday living. Current data indicate that patients survive well into adulthood.
Similar articles
-
[Congenital cataracts facial dysmorphism neuropathy syndrome--first Hungarian case report].Ideggyogy Sz. 2007 May 30;60(5-6):257-62. Ideggyogy Sz. 2007. PMID: 17578274 Hungarian.
-
Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome.Nat Genet. 2003 Oct;35(2):185-9. doi: 10.1038/ng1243. Epub 2003 Sep 21. Nat Genet. 2003. PMID: 14517542
-
Genetic identity of Marinesco-Sjögren/myoglobinuria and CCFDN syndromes.Neurology. 2002 Jan 22;58(2):231-6. doi: 10.1212/wnl.58.2.231. Neurology. 2002. PMID: 11805249
-
Marinesco-Sjögren syndrome in a male with mild dysmorphism.Am J Med Genet A. 2005 Mar 1;133A(2):197-201. doi: 10.1002/ajmg.a.30504. Am J Med Genet A. 2005. PMID: 15633176 Review.
-
[Autosomal recessive ethnic diseases of Czech Gypsies].Cas Lek Cesk. 2006;145(7):557-60; discussion 561. Cas Lek Cesk. 2006. PMID: 16921785 Review. Czech.
Cited by
-
CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.Cell Death Discov. 2019 Jun 19;5:105. doi: 10.1038/s41420-019-0185-3. eCollection 2019. Cell Death Discov. 2019. PMID: 31240132 Free PMC article.
-
Anesthesia of a patient with congenital cataract, facial dysmorphism, and neuropathy syndrome for posterior scoliosis: A case report.World J Clin Cases. 2022 May 6;10(13):4207-4213. doi: 10.12998/wjcc.v10.i13.4207. World J Clin Cases. 2022. PMID: 35665120 Free PMC article.
-
Terminal microdeletion of chromosome 18 in a Malaysian boy characterized with few features of typical 18q- deletion syndrome: a case report.J Med Case Rep. 2023 Jun 10;17(1):250. doi: 10.1186/s13256-023-03984-0. J Med Case Rep. 2023. PMID: 37296475 Free PMC article.
-
Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs.Biol Open. 2021 Jan 6;10(1):bio057232. doi: 10.1242/bio.057232. Biol Open. 2021. PMID: 33408128 Free PMC article.
-
Carboxy-terminal domain phosphatase 1 silencing results in the inhibition of tumor formation ability in gastric cancer cells.Oncol Lett. 2015 Nov;10(5):2947-2952. doi: 10.3892/ol.2015.3693. Epub 2015 Sep 10. Oncol Lett. 2015. PMID: 26722269 Free PMC article.
References
-
- Tournev I, Kalaydjieva L, Youl B, Ishpekova B, Guergueltcheva V, Kamenov O, Katzarova M, Kamenov Z, Raicheva-Terzieva M, King RH, Romanski K, Petkov R, Schmarov A, Dimitrova G, Popova N, Uzunova M, Milanov S, Petrova J, Petkov Y, Kolarov G, Aneva L, Radeva O, Thomas PK. Congenital Cataracts Facial Dysmorphism Neuropathy (CCFDN) syndrome, a novel complex genetic disease in Balkan Gypsies: clinical and electrophysiological observations. Ann Neurol. 1999;45:742–750. doi: 10.1002/1531-8249(199906)45:6<742::AID-ANA8>3.0.CO;2-N. - DOI - PubMed
-
- Varon R, Gooding R, Steglich C, Marns L, Tang H, Angelicheva D, Yong KK, Ambrugger P, Reinhold A, Morar B, Baas F, Kwa M, Tournev I, Guerguelcheva V, Kremensky I, Lochmuller H, Mullner-Eidenbock A, Merlini L, Neumann L, Burger J, Walter M, Swoboda K, Thomas PK, von Moers A, Risch N, Kalaydjieva L. Partial deficiency of the C-terminal domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nature Genet. 2003;35:185–189. doi: 10.1038/ng1243. - DOI - PubMed
-
- Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmüller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, de Pablo R, Kucinskas V, Kalaydjieva L. Mutation history of the Roma/Gypsies. Am J Hum Genet. 2004;75:596–609. doi: 10.1086/424759. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical